Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2006-03-14
2006-03-14
Weber, Jon (Department: 1653)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S002600, C530S321000
Reexamination Certificate
active
07012065
ABSTRACT:
The present invention relates to novel semi-synthetic cyclosporin analogs for the prevention of organ transplantation rejection and the treatment of immune disorders and inflammation, their use as pharmaceuticals and pharmaceutical composition comprising them, as well as the processes for the their production. The present invention provides a cyclosporin compound of the following Formula (1) or its pharmaceutically acceptable salt, ester or prodrug thereof. In the compound ofFormula (1), moiety “A” isWherein “X” and “Y” are defined herein.
REFERENCES:
patent: 4554351 (1985-11-01), Wenger
patent: 4798823 (1989-01-01), Witzel
patent: 5239057 (1993-08-01), Wang et al.
patent: 5427960 (1995-06-01), Wang et al.
patent: 5643870 (1997-07-01), Boelsterli et al.
patent: 5827706 (1998-10-01), Leitner et al.
patent: 6605593 (2003-08-01), Naicker et al.
patent: 2002/0132763 (2002-09-01), Naicker et al.
patent: 0 283 801 (1988-09-01), None
patent: 0296122 (1988-12-01), None
patent: 0 577 544 (1994-01-01), None
patent: 99/18120 (1999-04-01), None
patent: 99/65933 (1999-12-01), None
patent: 02/069902 (2002-09-01), None
patent: 03/030834 (2003-04-01), None
patent: 03/033010 (2003-04-01), None
patent: 2004/050687 (2004-06-01), None
Hogg, J. C. (2004) Pathophysiology of airflow limitation in chronic obstructive pulmonary disease. Lancet. 2004. vol. 364, pp. 709-721.
Billich et al., Enzymatic Synthesis of CsA,J. Biol. Chem., 262, 17258-17259 (1987).
Faulds et al., Cyclosporin: A Review of its Pharmacodynamic and Pharmacokinetic Properties, and Therpeutic Use in Immunoregulatory Disorders,Drugs46, 953-1040 (1993).
Chen Jason Shih-Hao
Lazarova Tsvetelina
Or Yat Sun
Edwards & Angell LLP
Enanta Pharmaceuticals, Inc.
Hsi Jeffrey D.
Liu Samuel W.
LandOfFree
Cyclosporins for the treatment of immune disorders does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cyclosporins for the treatment of immune disorders, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cyclosporins for the treatment of immune disorders will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3585347